Drug Profile
Research programme: 5-lipoxygenase inhibitors - Qurient Co
Alternative Names: 5-LO inhibitors - Qurient CoLatest Information Update: 01 Sep 2022
Price :
$50
*
At a glance
- Originator Qurient Co
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Skin disorder therapies
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Asthma
Most Recent Events
- 01 Sep 2022 Early research is ongoing in Asthma in South Korea (PO) (Qurient pipeline, September 2022)
- 18 Jun 2020 Early research in Asthma is ongoing in South Korea (PO) (Qurient pipeline, June 2020)
- 14 Sep 2016 Early research in Asthma in South Korea (unspecified route) before September 2016